Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer's disease

Brain

Volumn 135, Issue 10, 2012, Pages 3039-3050

  Dorr, Adrienne ^a   Sahota, Bhupinder ^a   Chinta, Lakshminarayan V ^a,b   Brown, Mary E ^b   Lai, Aaron Y ^b   Ma, Keran ^b   Hawkes, Cheryl A ^c   McLaurin, Joanne ^b   Stefanovic, Bojana ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

cerebral amyloid angiopathy; microvasculature; scyllo inositol; two photon fluorescence microscopy; vessel tortuosity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; INOSITOL; SCYLLO INOSITOL; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CORTEX; CONTROLLED STUDY; HYPERCAPNIA; MICROVASCULAR ISCHEMIA; MICROVASCULARIZATION; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS; VENULE;

EID: 84867722515     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws243     Document Type: Article

References (54)

1. Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, et al. SRF and myocardin regulate LRP-mediated amyloid-b clearance in brain vascular cells. Nat Cell Biol 2009; 11: 143-53.
2. Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, et al. Consequence of A immunization on the vasculature of human Alzheimer's disease brain. Brain 2008; 131: 3299-310.
3. Bullitt E, Gerig G, Pizer SM, Lin W, Aylward SR. Measuring tortuosity of the intracerebral vasculature from MRA images. IEEE Trans Med Imaging 2003; 22: 1163-71.
4. Butterfield DA. Amyloid-b-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002; 36: 1307-13.
5. Carrano A, Hoozemans JJM, van der Vies SM, Rozemuller AJM, van Horssen J, de Vries HE. Amyloid beta induces oxidative stressmediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 2011; 15: 1167-78.
6. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001; 276: 21562-70.
7. Choi JK, Carreras I, Dedeoglu A, Jenkins BG. Consequence of Ab immunization on the vasculature of human Alzheimer's disease brain. Neuropharmacology 2010; 59: 353-7.
8. Christie R, Yamada M, Moskowitz M, Hyman B. Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 2001; 158: 1065-71.
9. Citron M. Alzheimer's disease: treatments in discovery and development. Nat Neurosci 2002; 5 (Suppl): 1055-7.
10. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev 2000; 24: 365-74.
11. Deane R, Wu Z, Sagare A, Davis J, Yan SD, Hamm K, et al. LRP/Amyloid-b-peptide interaction mediates differential brain efflux of Ab-isoforms. Neuron 2004; 43: 333-44.
12. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981; 7: 519-79.
13. Fenili D, Brown ME, Rappaport RV, McLaurin J Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J Mol Med 2007; 85: 603-12.
14. Fenili D, Weng YQ, Aubert I, Nitz M, McLaurin J. Sodium/myo-inositol transporters: an examination of substrate transport requirements and regional brain expression in the TgCRND8 mouse model of Alzheimer's disease. PLoS One 2011; 6: e24032.
15. Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture in selected areas of brains with Alzheimer's disease. Acta Neuropathol 1990; 79: 672-9.
16. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006; 100: 328-35.
17. Greenberg SM. Cerebral amyloid angiopathy and vessel dysfunction. Cerebrovasc Dis 2002; 13 (Suppl 2): 42-47.
18. Han BH, Zhou M-l, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, et al. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-b peptide, partial restoration via-secretase inhibition. J Neurosci 2008; 28: 13542-50.
19. Hawkes CA, McLaurin J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. PNAS 2009; 106: 1261-6.
20. Herzig MC, Van Nostrand WE, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol 2006; 6: 40-54.
21. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008; 39: 1127-33.
22. Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. Plos ONE 2012; 7: e36893.
23. Kalaria RN. Cerebral vessels in ageing and Alzheimer's disease. Pharmacol Ther 1996; 72: 193-214.
24. Kalaria RN. Small vessel disease and Alzheimer's dementia: pathological considerations. Cerebrovasc Dis 2002; 13 (Suppl2): 48-52.
25. Kasischke KA, Lambert EM, Panepento B, Sun A, Gelbard HA, Burgess RW, et al. Two-photon NADH imaging exposes boundaries of oxygen diffusion in cortical vascular supply regions. J Cereb Blood Flow Metab 2011; 31: 68-81.
26. Kershaw L, Cheng H. A general dual-bolus approach for quantitative DCE-MRI. Magn Reson Imaging 2011; 29: 160-6.
27. Kim J, Leira E, Callison R, Ludwig B, Moritani T, Magnotta V, et al. Toward fully automated processing of dynamic susceptibility contrast perfusion MRI for acute ischemic cerebral stroke. Comput Methods Programs Biomed 2010; 98: 204-13.
28. Kwan AC, Duff K, Gouras GK, Webb WW. Optical visualization of Alzheimer's pathology via multiphoton-excited intrinsic fluorescence and second harmonic generation. Opt Express 2009; 17: 3679-89.
29. LeVine H III. Small molecule inhibitors of Abeta assembly. Amyloid 2007; 14: 185-97.
30. Lindvere L, Dorr A, Stefanovic B. Two-photon fluorescence microscopy of cerebral hemodynamics. Cold Spring Harb Protoc 2010 (9):pdb. prot5494.
31. Ma K, Mount HT, McLaurin J. Region-specific distribution of b-amyloid peptide and cytokine expression in TgCRND8 mice. Neurosci Lett 2011; 492: 5-10.
32. McLaurin J, Golomb R, Jurewicz A, Antel JP, Fraser PE. Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta-induced toxicity. J Biol Chem 2000; 275: 18495-502.
33. McLaurin J, Kierstead ME, Brown ME, Hawkes CA, Lambermon MH, Phinney AL, et al. Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model. Nat Med 2006; 12: 801-8.
34. Miao J, Xu F, Davis J, Otte-Höller I, Verbeek MM, Van Nostrand WE. Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am J Pathol 2005; 167: 505-15.
35. Nicolakakis N, Hamel E. Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab 2011; 31: 1354-70.
36. Nicoll JA, Yamada M, Frackowiak J, Mazur-Kolecka B, Weller RO. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 2004; 25: 589-97.
37. Nishimura N, Schaffer CB, Friedman B, Lyden PD, Kleinfeld D. Penetrating arterioles are a bottleneck in the perfusion of neocortex. Proc Natl Acad Sci USA 2007; 104: 365-70.
38. Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med 2007; 204: 1999-2008.
39. Perlmutter LS. Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol 1994; 9: 33-40.
40. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study. Neurology 2002; 58: 1629-34.
41. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer; 2000.
42. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010; 362: 329-44.
43. Scharrer E. Arteries and veins in the mammalian brain. Anat Rec 1940; 78: 173-96.
44. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011; 1: a006189.
45. Shin HK, Jones PB, Garcia-Alloza M, Borrelli L, Greenberg SM, Bacskai BJ, et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 2007; 130 (Pt 9): 2310-19.
46. Stefanovic B, Hutchinson E, Yakovleva V, Schram V, Russell JT, Belluscio L, et al. Functional reactivity of cerebral capillaries. J Cereb Blood Flow Metab 2008; 28: 961-72.
47. Takano T, Han X, Deane R, Zlokovic B, Nedergaard M. Two-photon imaging of astrocytic Ca2 + signaling and the microvasculature in experimental mice models of Alzheimer's disease. Ann NY Acad Sci 2007; 1097: 40-50.
48. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M. b-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 1996; 380: 168-71.
49. Thore CR, Anstrom JA, Moody DM, Challa VR, Marion MC, Brown WR. Morphometric analysis of arteriolar tortuosity in human cerebral white matter of preterm, young, and aged subjects. J Neuropathol Exp Neurol 2007; 66: 337-45.
50. Tian J, Shi J, Smallman R, Iwatsubo T, Mann DM. Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol Appl Neurobiol 2006; 32: 332-40.
51. Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, et al. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers. Ann Neurol 2006; 60: 668-76.
52. Verbeek MM, De Waal RM, Schipper JJ, Van Nostrand WE. Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 1997; 68: 1135-41.
53. Weller RO, Nicoll JA. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 2003; 25: 611-6.
54. Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimer's Res Ther 2009; 1: 6(doi:10.1186/alzrt6).